These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28611048)

  • 1. Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells.
    Rohira AD; Yan F; Wang L; Wang J; Zhou S; Lu A; Yu Y; Xu J; Lonard DM; O'Malley BW
    Cancer Res; 2017 Aug; 77(16):4293-4304. PubMed ID: 28611048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1.
    Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; O'Malley BW
    Mol Endocrinol; 2011 Dec; 25(12):2041-53. PubMed ID: 22053001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1.
    Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; Wang J; Qi R; Matzuk AJ; Song X; Madoux F; Hodder P; Chase P; Griffin PR; Zhou S; Liao L; Xu J; O'Malley BW
    Cancer Res; 2014 Mar; 74(5):1506-1517. PubMed ID: 24390736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death.
    Wang L; Yu Y; Chow DC; Yan F; Hsu CC; Stossi F; Mancini MA; Palzkill T; Liao L; Zhou S; Xu J; Lonard DM; O'Malley BW
    Cancer Cell; 2015 Aug; 28(2):240-52. PubMed ID: 26267537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.
    Eedunuri VK; Rajapakshe K; Fiskus W; Geng C; Chew SA; Foley C; Shah SS; Shou J; Mohamed JS; Coarfa C; O'Malley BW; Mitsiades N
    Mol Endocrinol; 2015 Aug; 29(8):1170-83. PubMed ID: 26066330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.
    Rohira AD; Lonard DM
    Biochem Pharmacol; 2017 Sep; 140():1-7. PubMed ID: 28390937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An acetylation-enhanced interaction between transcription factor Sox2 and the steroid receptor coactivators facilitates Sox2 transcriptional activity and function.
    Huang Y; Duan X; Wang Z; Sun Y; Guan Q; Kang L; Zhang Q; Fang L; Li J; Wong J
    J Biol Chem; 2021 Dec; 297(6):101389. PubMed ID: 34762910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer.
    Lee WK; Kim WG; Fozzatti L; Park S; Zhao L; Willingham MC; Lonard D; O'Malley BW; Cheng SY
    Endocr Relat Cancer; 2020 Apr; 27(4):209-220. PubMed ID: 31977311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of verrucarin a as a potent and selective steroid receptor coactivator-3 small molecule inhibitor.
    Yan F; Yu Y; Chow DC; Palzkill T; Madoux F; Hodder P; Chase P; Griffin PR; O'Malley BW; Lonard DM
    PLoS One; 2014; 9(4):e95243. PubMed ID: 24743578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression.
    Bhummaphan N; Petpiroon N; Prakhongcheep O; Sritularak B; Chanvorachote P
    Phytomedicine; 2019 Sep; 62():152932. PubMed ID: 31100681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of improved SRC-3 inhibitors as breast cancer therapeutic agents.
    Qin L; Chen J; Lu D; Jain P; Yu Y; Cardenas D; Peng X; Yu X; Xu J; Wang J; O'Malley BW; Lonard DM
    Endocr Relat Cancer; 2021 Aug; 28(10):657-670. PubMed ID: 34310341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3.
    Song X; Chen J; Zhao M; Zhang C; Yu Y; Lonard DM; Chow DC; Palzkill T; Xu J; O'Malley BW; Wang J
    Proc Natl Acad Sci U S A; 2016 May; 113(18):4970-5. PubMed ID: 27084884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma.
    Song X; Chen H; Zhang C; Yu Y; Chen Z; Liang H; Van Buren G; McElhany AL; Fisher WE; Lonard DM; O'Malley BW; Wang J
    Cancer Lett; 2019 Feb; 442():310-319. PubMed ID: 30423406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell.
    Nishi M; Akutsu H; Kudoh A; Kimura H; Yamamoto N; Umezawa A; Lee SW; Ryo A
    Oncotarget; 2014 Sep; 5(18):8665-80. PubMed ID: 25228591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
    Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
    Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
    Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD
    Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.
    Karmakar S; Foster EA; Smith CL
    Endocrinology; 2009 Apr; 150(4):1588-96. PubMed ID: 19095746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockout of SRC-1 and SRC-3 in Mice Decreases Cardiomyocyte Proliferation and Causes a Noncompaction Cardiomyopathy Phenotype.
    Chen X; Qin L; Liu Z; Liao L; Martin JF; Xu J
    Int J Biol Sci; 2015; 11(9):1056-72. PubMed ID: 26221073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel SRC-2-dependent regulation of epithelial-mesenchymal transition in breast cancer cells.
    Bozickovic O; Skartveit L; Engelsen AST; Helland T; Jonsdottir K; Flågeng MH; Fenne IS; Janssen E; Lorens JB; Bjørkhaug L; Sagen JV; Mellgren G
    J Steroid Biochem Mol Biol; 2019 Jan; 185():57-70. PubMed ID: 30048685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines.
    Lin CH; Shen YA; Hung PH; Yu YB; Chen YJ
    BMC Complement Altern Med; 2012 Oct; 12():201. PubMed ID: 23110507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.